Literature DB >> 8495423

Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by gamma-interferon.

D H Munn1, E Armstrong.   

Abstract

In this study we continue our examination of the unique form of antibody-dependent antitumor cytotoxicity (ADCC) which develops when human monocytes are exposed to macrophage colony-stimulating factor (MCSF) in vitro. This form of ADCC is not present in fresh monocytes and emerges only as monocytes differentiate into monocyte-derived macrophages (MDM). We now report that the presence of gamma-interferon (IFN-gamma) during this period of differentiation markedly affects the development of MCSF-induced cytotoxicity. The addition of IFN-gamma on day 0 resulted in a pronounced dose-dependent inhibition of ADCC measured on day 7 (mean inhibition, 76 +/- 12%; range, 66-94%). MDM exposed to MCSF plus IFN-gamma required 3-10-fold higher effector to target cell ratios to achieve a level of cytotoxicity comparable to that of MDM cultured with MCSF alone. This inhibitory effect was attributable to an IFN-gamma-induced shift in the basic mechanism of target cell killing, away from the phagocytic form normally seen with MCSF and toward a significantly less effective extracellular form. In order to influence ADCC, IFN-gamma had to be present prior to the onset of differentiation; if it was added later it had progressively less effect, and if it was added after differentiation was complete it was inactive. The modulatory effects of IFN-gamma also extended to a number of other developmentally regulated attributes. MDM cultured with MCSF normally acquired a characteristic morphology and immunophenotype, re-entered the cell cycle, and changed functionally from accessory cells for mitogen-induced lymphocyte activation to suppressor cells. The presence of IFN-gamma prevented the emergence of each of these attributes. Despite these negative effects, MDM exposed to IFN-gamma remained viable, continued to bind and internalize MCSF, and displayed superior accessory cell function and oxidative burst activity. Taken together, our findings suggest that human monocytes are capable of following at least two distinct differentiation pathways in response to the local cytokine environment, with significant impact on the resultant macrophage phenotype in general and antitumor cytotoxicity in particular.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8495423

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Aortic endothelial cells regulate proliferation of human monocytes in vitro via a mechanism synergistic with macrophage colony-stimulating factor. Convergence at the cyclin E/p27(Kip1) regulatory checkpoint.

Authors:  A S Antonov; D H Munn; F D Kolodgie; R Virmani; R G Gerrity
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

2.  GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder.

Authors:  R A Baiocchi; J S Ward; L Carrodeguas; C F Eisenbeis; R Peng; S Roychowdhury; S Vourganti; T Sekula; M O'Brien; M Moeschberger; M A Caligiuri
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

3.  Antibody-independent phagocytosis of tumor cells by human monocyte-derived macrophages cultured in recombinant macrophage colony-stimulating factor.

Authors:  D H Munn; N K Cheung
Journal:  Cancer Immunol Immunother       Date:  1995-07       Impact factor: 6.968

4.  Lysosomal cholesterol accumulation inhibits subsequent hydrolysis of lipoprotein cholesteryl ester.

Authors:  W Gray Jerome; Brian E Cox; Evelyn E Griffin; Jody C Ullery
Journal:  Microsc Microanal       Date:  2008-03-03       Impact factor: 4.127

5.  Inhibition of T cell proliferation by macrophage tryptophan catabolism.

Authors:  D H Munn; E Shafizadeh; J T Attwood; I Bondarev; A Pashine; A L Mellor
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307

6.  Limited Effect of Indolamine 2,3-Dioxygenase Expression and Enzymatic Activity on Lupus-Like Disease in B6.Nba2 Mice.

Authors:  Laura M Davison; Jessica C Liu; Lei Huang; Thomas M Carroll; Andrew L Mellor; Trine N Jørgensen
Journal:  Front Immunol       Date:  2019-08-27       Impact factor: 7.561

7.  Comparative study of the effect of LPS on the function of BALB/c and C57BL/6 peritoneal macrophages.

Authors:  Sara Soudi; Ahmad Zavaran-Hosseini; Zuhair Muhammad Hassan; Masoud Soleimani; Fatemeh Jamshidi Adegani; Seyed Mahmoud Hashemi
Journal:  Cell J       Date:  2013-05-05       Impact factor: 2.479

8.  Manifestations of immune tolerance in the human female reproductive tract.

Authors:  Gary F Clark; Danny J Schust
Journal:  Front Immunol       Date:  2013-02-13       Impact factor: 7.561

9.  Activation-induced apoptosis in human macrophages: developmental regulation of a novel cell death pathway by macrophage colony-stimulating factor and interferon gamma.

Authors:  D H Munn; A C Beall; D Song; R W Wrenn; D C Throckmorton
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

10.  IL4I1 Is a Novel Regulator of M2 Macrophage Polarization That Can Inhibit T Cell Activation via L-Tryptophan and Arginine Depletion and IL-10 Production.

Authors:  Yinpu Yue; Wei Huang; Jingjing Liang; Jing Guo; Jian Ji; Yunliang Yao; Mingzhu Zheng; Zhijian Cai; Linrong Lu; Jianli Wang
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.